NCT07125547 2025-08-15Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral CancerTianjin Medical University Second HospitalPhase 2 Recruiting35 enrolled
NCT05756569 2025-07-28Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant HistologyEmory UniversityPhase 2 Recruiting25 enrolled